Pathos AI will apply its Foundry platform to Tempus AI's neurological dataset to track patient outcomes and speed research into Alzheimer's disease biology.

From the articleAI drug development startup Pathos AI closes $237M investment - SiliconANGLEAlso in Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development | Reuters